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AbstrACt
Objectives End-stage kidney disease disproportionately 
affects people of South Asian origin. This study aimed to 
uncover the lived experiences of this group of patients 
on centre-based haemodialysis (HD), the most prevalent 
dialysis modality.
Design The study utilised a qualitative focus group 
methodology. Seven focus groups were conducted across 
four NHS Trusts in the UK including three in Gujarati and 
two each in Punjabi and Urdu. This provided an inclusive 
opportunity for South Asian patients to contribute in their 
language of origin. A total of 24 patients participated. 
Focus groups were facilitated by bilingual project workers 
and data were forward translated and analysed using 
thematic analysis.
results Four themes were identified. This included (1) 
‘treatment imposition’, which comprised of the restrictive 
nature of HD, the effects of treatment and the feeling of 
being trapped in an endless process. (2) The ‘patient–
clinician relationship’ centred around the impact of a 
perceived lack of staff time, and inadequacies in the 
quality of interactions. (3) ‘Coping strategies’ highlighted 
the role of cognitive reappraisal, living in the moment and 
family support networks in facilitating adjustment. (4) 
‘Pursuit of transplantation’ included equating this form 
of treatment with restoring normality, alongside cultural 
factors limiting hopefulness for receiving an organ.
Conclusions In general, the experiences of South Asian 
patients receiving HD were not unique to this ethnic 
group. We did find distinct issues in relation to interactions 
with healthcare professionals, views on access to 
transplantation and the importance of family support 
networks. The study provides useful insights which may 
help enhance culturally tailored renal care.
IntrODuCtIOn
Patients with end-stage kidney disease (ESKD) 
require some form of kidney function replace-
ment in order to survive. In the UK, more 
than one person in every thousand receives 
such treatment, the most common forms of 
which are kidney transplantation and haemo-
dialysis (HD).1 HD involves removal of toxins 
from the patient’s blood by passage through 
a dialysis machine. This requires access to the 
patient’s bloodstream through a surgically 
created fistula or a permanent intravenous 
line. Treatment needs to be conducted regu-
larly, usually thrice weekly with each session 
lasting around 4 hours.
While HD is a lifesaving treatment, it is 
physically and psychologically demanding. 
Studies have demonstrated the high symptom 
burden associated with treatment including 
symptoms during dialysis, such as headaches, 
low blood pressure, fatigue (both generally 
and postdialysis in particular)2 3 and sleep 
disturbances.4 5 Additionally, patients need to 
contend with dietary and fluid restrictions,6–8 
high pill burden9 10 and often struggle to 
participate in life activities.11 The frequency 
of HD treatments is an added stressor.12 13
Although there is considerable literature 
exploring patient perspectives of life on HD, 
there has been little focus on ethnic minori-
ties, relating in part to language and cultural 
barriers.14 This represents an important gap 
in knowledge, since a significant proportion 
strengths and limitations of this study
 ► The use of qualitative focus group methodology 
allowed for in-depth exploration of patient experi-
ences, and has resulted in new knowledge on how 
members of ethnic minorities experience haemodi-
alysis (HD) care.
 ► The opportunity for patients to engage in focus 
groups in their language of origin overcame barriers 
that may otherwise prevent participation in research.
 ► The bilingual project workers who facilitated focus 
groups were unrelated to patient renal care and 
so were able to more effectively encourage par-
ticipation so that all individuals contributed to the 
discussions.
 ► The self-selecting nature of patient participants may 
have resulted in recruitment bias such that only 
those with strong views about HD participated.
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(22.7%) of UK service users identify themselves as having 
a Black and Asian Minority Ethnic (BAME) background,1 
the largest group being those originating from South Asia 
(11.8%).1 South Asian refers here to people with origins 
in India, Pakistan, Bangladesh and Sri Lanka. Compared 
with their white-European counterparts, people of South 
Asian origin are at increased risk of developing ESKD.15 16 
The mechanisms for vulnerability are likely to be related 
to susceptibility to risk factors such as diabetes.17 South 
Asians are more likely to develop ESKD at a younger age18 
and have a faster rate of symptom progression.19 They are 
also likely to wait longer for a renal transplant primarily 
due to reduced rates of organ donation among people of 
this ethnicity.20
Currently, little is known about how South Asian 
patients adjust to and cope with HD. The limited data 
available suggest perceptions of reduced quality of life 
when compared with white-Europeans,21 together with 
increased symptom burden both during and between 
HD sessions.2 There may also be problems with referral 
processes, particularly for those moving from diabetic to 
renal services.22 This lack of data has been recognised in 
the inaugural UK Renal Research Strategy, which states 
that efforts should be made to increase access to research 
for those from BAME groups.23
We sought to provide South Asian patients with a cultur-
ally tailored opportunity to share their thoughts, feel-
ings and experiences of HD, in relation to the processes 
involved in HD treatment and its impact on their lives. We 
utilised a qualitative focus group approach, since it offers 
an in-depth account of patient perspectives and so may 
generate important findings for both healthcare policy 
and clinical practice.24
MethODs
The research is reported according to the Consolidated 
Criteria for Reporting Qualitative Studies.25 A semi-
structured focus group topic guide was devised by the 
authors, a multiprofessional team with expertise in health 
psychology, nephrology, patient and public involvement, 
qualitative methods and psychological care. The topic 
guide (table 1) included seven items across three core 
areas: patient perspectives on HD and its impact on their 
life, thoughts and feelings in relation to health and support 
mechanisms. Probing questions were asked as appropriate 
to encourage patients to expand on their answers. Since 
research with South Asian patients is limited, the topic 
guide was kept purposefully broad in order to encourage 
patients to discuss elements of their experience that are 
most meaningful to them as opposed to being guided by 
existing literature. First developed in English, the topic 
guide was forward translated into Gujarati, Punjabi and 
Urdu by a team of bilingual project workers with a back-
ground of working in healthcare contexts and with 
patients of South Asian origin. Four project workers were 
employed working with patients from ethnic minorities 
as peer educators, in community liaison and nursing. Two 
others had experience in supporting healthcare research 
with members of BAME groups. The majority of project 
workers (83%) were female. We recruited two project 
workers in each language who independently translated 
the topic guide and met to reconcile any disagreements. 
The project workers also attended three training days 
focused on the conceptual background and aims of the 
study, research processes, translation processes and tran-
scription. Training was delivered by a multidisciplinary 
team.
setting
The research was based across four UK NHS Renal Units 
with high proportions of patients from South Asian back-
grounds (18%–30%).1 Patients were given the option to 
attend focus groups on dialysis or non-dialysis days. On 
HD days, this could be before or after treatment and the 
focus groups were then scheduled based on the prefer-
ence of the majority.
Participants and recruitment
An initial audit was carried out by each NHS Trust to 
estimate the proportions of patients who identified 
themselves with different South Asian subgroups. This 
identified three main languages: Gujarati, Punjabi and 
Urdu. This captured those with origins in India and Paki-
stan including Gujarati speaking Hindus and Punjabi 
speaking Sikhs from India, and Urdu speaking Muslims 
from India and Pakistan. Focus groups were conducted 
in the language of origin so as to provide patients equal 
opportunities to contribute. Eligible patients were iden-
tified by their consultant nephrologist. Inclusion criteria 
were age over 18 years, receiving HD for at least 6 months, 
and verbally fluent in one of the target languages. Patients 
who had received treatment for mental health problems 
within the last year were excluded. Eligible patients were 
provided with a written information sheet by a member 
of the renal care team, usually someone with the appro-
priate language skills. Those interested in the study were 
asked to consent to their information being passed onto 
Table 1 Focus group topic guide
Topic guide area Questions
Impact of 
haemodialysis
How has your life changed since 
starting dialysis?
Which aspects of your life have been 
most affected?
Are you happy with the treatment that 
you receive?
Thoughts and 
feelings about health
How do you feel about your situation?
Do you have any concerns about your 
future health?
What bothers you most about your 
health at present? 
Support What has helped you to cope with 
the lifestyle changes associated with 
dialysis?
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the research team. Each patient then received a follow-up 
telephone call from a bilingual project worker who 
provided further information and details of the focus 
groups. At the focus groups, patients were reminded about 
the particulars of the research and informed consent was 
taken by a bilingual project worker supported by the study 
co-ordinator (RM). The focus groups began by patients 
introducing themselves and then moved through areas of 
the topic guide. At the end of the focus group, patients 
were debriefed and thanked.
Data analysis
All focus groups were audio recorded with consent from 
patients and transcribed verbatim by the associated 
project worker. The project worker then forward trans-
lated the transcripts  into English. At this stage, a second 
bilingual project worker independently reviewed the tran-
script to provide assurance of the quality of translation, 
with a particular focus on retaining meaning. Data were 
analysed by SS and MK in NVivo qualitative software V.10 
and using thematic analysis as described by Braun and 
Clarke.26 Transcripts were first read and reread to form 
initial impressions of the data. We then progressed to 
code interesting aspects of the data and started to group 
similar ideas and concepts together. On this basis, a code-
book was agreed on and analysis progressed to revise the 
codes and to identify overarching themes that subsumed 
them. Verbatim text from the focus groups was incorpo-
rated to further elucidate the themes. It is important to 
mention that recognising the lack of robust guidelines 
on attaining data or theoretical saturation in qualitative 
studies,27 we defined saturation in this research as the 
point at which patient participants were not ‘telling us 
anything new’ and our codebook had been stabilised. 
This was achieved by analysis of the fourth focus group 
and so we are confident that at the level of the higher 
order concepts we sought to explore, our themes accu-
rately capture the range of experiences that patient had 
to share. Ongoing discussion between SS and MK, and 
SS and the project workers throughout data analysis also 
helped to ensure that the themes accurately represented 
what patients conveyed within the focus groups. While 
deploying two coders increased resource demands, the 
added benefits were the different perspectives that SS 
and MK brought to the task, given their differing research 
experiences, together with the opportunity it presented to 
discuss the coding in-depth, to resolve disagreements and 
to refine the codebook and themes. RM also coded 20% 
of the transcripts. Cohen’s kappa was used to calculate 
inter-rater reliability. This indicated substantial agree-
ment27 with a k value of 0.80.
Patient and public involvement
Patient involvement was essential to identifying the need 
for the research, the development of the recruitment 
strategy and the interpretation of findings. KM has expe-
rience as both a HD patient and kidney transplant recip-
ient and is also an active member of a number of patient 
advocacy groups. This breadth of experience allowed KM 
to provide feedback throughout the development of the 
research proposal, and at key junctures of the research 
process including data interpretation and dissemination 
of findings.
results
Seven focus groups were conducted. This included two in 
each Urdu and Punjabi and three in Gujarati according 
to the language needs of patients based at the included 
NHS Trusts. Focus groups lasted from 45 min to 1.5 hours, 
and included three to four patients. Twenty-four patients 
participated (M age=57.4; SD=8.9) including 14 males 
and 10 females. Four themes emerged from the data.
theme 1: treatment imposition
Patients were forthcoming with examples of how HD had 
imposed on their lives. Notably, their experiences related 
to the ‘restrictive’ nature of HD, ‘treatment effects’ and a 
sense of being stuck in an ‘endless process’. There were 
multiple attributes linked to perceiving HD to be restric-
tive, stemming mainly from treatment frequency and 
the impact this had on engagement with a wide range of 
activities and restricting patient autonomy over life partic-
ipation. Such feelings are highlighted in the following 
extract:
I can’t go on holidays. If I want to go out far, then I 
have to think twice about it as have to be back for di-
alysis the next day. That is a problem (Gujarati focus 
group 2, patient 2, male).
A further example of patients feeling as though dial-
ysis restricted life participation includes conflict between 
treatment attendance and cultural needs such as 
observing prayers.
Recently with my having to attend cultural prayers 
and the last 3 days I have been running around and 
luckily yesterday afternoon I got dialysis and I was 
able to go to the prayer but this is my example but 
when this happens and a person gets pulled by cultur-
al needs it debilitates a person (Gujarati focus group 
1, patient 2, female).
Treatment effects were also wide ranging. A minority 
reported side effects of medication such as altered taste.
I have a problem with eating as too much medication 
has made the tongue feel bitter (Gujarati focus group 
2, patient 4, female).
Other treatment effects described as problematic were 
predominantly associated with HD (during or in-between 
sessions) such as feeling weak, experiencing low blood 
pressure and headaches.
I feel like going out but don’t feel well enough. I ei-
ther have a headache or my legs ache, I feel weak. I do 
want to go out for a short walk but the body doesn’t 
 o
n
 20 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-024739 on 16 May 2019. Downloaded from 
4 Sharma S, et al. BMJ Open 2019;9:e024739. doi:10.1136/bmjopen-2018-024739
Open access 
allow you to do what you want (Gujarati focus group 
2, patient 3, female).
When you come off dialysis, your whole body aches. 
And you don’t have the strength. It takes probably all 
evening to get back to normal, or the next day (Urdu 
focus group 2, patient 3, male).
A final imposition of treatment was the feeling that 
patients are stuck in and endless process where they 
have no choice over their circumstances, which led to 
despondency.
Sometimes we [referring to the whole focus group] 
don’t feel like coming, but we don’t have a choice, we 
have to (Urdu focus group 1, patient 4, female).
Yes, keep going, you have no choice (Punjabi focus 
group 1, patient 1, male).
theme 2: patient–clinician relationship
As part of discussing life on dialysis, the patient–clinician 
relationship featured as a central factor that impacted 
overall perceptions of healthcare. This included some 
patients feeling dissatisfaction about a perceived ‘lack of 
time’ available from nephrologists:
The doctors don’t have time. We try to meet with 
them as regularly as possible (Punjabi focus group 2, 
patient 3, female).
Additionally, it was clear that patients were divided 
in their experiences of healthcare professionals due 
to perceived inadequacy in quality of interactions. The 
following example illustrates this:
The doctors they just give you the medication, use 
this. They don’t explain. Take this medication, what is 
going in your body they don’t explain about it. They 
don’t tell you what is going wrong or what you have to 
do. Just this is your prescription, take the medication. 
Their responsibility is finished (Urdu focus group 1, 
patient 5, female).
Perceived difficulties in developing positive patient–
clinician interactions were in part enhanced by language 
barriers that prevented patients from directly communi-
cating with their healthcare professional, rendering the 
family support network as crucial.
I do not understand what he [referring to the ne-
phrologist] says. When there is a meeting, my daugh-
ter writes down the points and gives me (Gujarati 
focus group 2, patient 2, male).
Some [referring to others that the patient interacted 
with] don’t know at all…like mostly the elderly need 
to take someone in…if it’s an English doctor, they’ll 
need to take someone in to understand (Punjabi 
focus group 1, patient 2, male).
theme 3: coping strategies
Despite noting a range of negative impositions on life 
brought about by HD and its associated complexities, 
patients recognised a need to maintain a positive outlook. 
This was driven by the ‘cognitive re-appraisal’ that HD 
was at least a lifeline and that it was more psychologically 
helpful to ‘live in the moment’. For example, patients 
described HD as extending their life and giving them a 
second chance:
I think that I have received a bonus life. This is my 
bonus life. It is hard. But I have been given another 
chance in this world. My view is that whatever time 
holds you should remain happy. Positive thinking. We 
do think on the other side too, like when we go on 
the machine, we have a lot of tension in our mind, 
but we should still think this is still good for us (Urdu 
focus group 1, patient 1, female).
Patients also felt that it was more constructive to live in 
the moment rather than dwell on negativity:
You need to take each day as it comes and live mind-
fully (Gujarati focus group 1, patient 3, male).
Additionally, patients perceived receiving support from 
the ‘family network’ as extremely important in helping 
them to contend with HD. Family offered two types of 
support. First, ‘practical support’ in multiple domains 
related to treatment itself such as communicating with 
professionals on their behalf for those who had no or 
limited English language skills (as described in Theme 
3: coping strategies section). Second, family offered 
emotional comfort in facing patient circumstances with 
the majority viewing them as the first and often only 
source of support:
There are low moods, apart from your children who 
are close to you, only they understand you (Urdu fo-
cus group 1, patient 4, female).
Having a good family unit is very important, very 
important I think. You know your close family. They 
can help you, they can help cheer you up, they look 
after you (Punjabi focus group 1, patient 2, male).
theme 4: pursuit of transplantation
Given the challenges associated with HD, the majority 
of patients described a kidney transplant as a route 
to improving their quality of life. Transplantation was 
equated to ‘normality’ as described in the following 
extract:
I have been coming here since 8 years, I don’t get a 
response as to whether I will get a kidney or not. I 
think if I get a transplant, then the next 8–10 years 
of my life would go in peace (Gujarati focus group 2, 
patient 2, male).
However, there was a ‘loss of hopefulness’ for trans-
plantation relating to an awareness of a lack of suitable 
or willing donors, especially those from ethnic minorities. 
The following quotes demonstrate the perception that 
live donation may be less likely among the South Asian 
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community owing to a lack of knowledge and awareness 
of the process.
That’s the thing. It’s because Indian’s don’t have 
enough information. Like they haven’t said that Mr 
Singh gave his kidney away to his sister and that per-
son is still well. Whereas English people, they have 
the information about so and so gave this. They can 
see people who have done it. They can feel satisfied 
that this person has given it away and that they are 
still OK and that I am also OK to do it. And we [refer-
ring to own community] don’t have that system, be-
cause no-one does it that much (Punjabi focus group 
1, patient 1, male).
Furthermore, patients reported that when discussing 
transplantation with potential live donors they were met 
by disbelief that this was a possibility.
I’ve been waiting for years and I’ve had enough so if 
anything can be done about a transplant, that would 
be appreciated…I’ve been told that a person can sur-
vive on one kidney, but when I tell others they don’t 
believe me; I think they are scared (Punjabi focus 
group 2, patient 2, male).
DIsCussIOn
Using focus group methodology, we highlight how 
patients from South Asian backgrounds experience 
life on HD. The findings concur with existing research 
suggesting that there are consistent aspects of treatment 
via HD, which patients find difficult to contend with and 
consequently employ a number of strategies to help them 
cope.12 28 29 The major contribution of our study is identi-
fying that South Asian patients often report difficulties in 
developing positive patient–clinician relationships, which 
may lead to perceived health disparities, alongside the 
loss of hope for escaping the HD treatment regimen due 
to the availability of donor kidneys.
Our patients echoed the treatment impositions of HD 
such as the frequency of sessions restricting engagement 
with day-to-day activities and limiting general autonomy in 
life. Additionally, patients were forthcoming in expressing 
the added treatment effects that are problematic both 
during and between HD sessions. Since HD is a lifesaving 
treatment, the impact on symptom burden may be over-
looked,2 but it is important to note the range of factors 
that patients may need support with when adjusting to a 
new way of living. For example, in their qualitative study 
concerning the experience of fatigue in HD patients, 
Horigan et al30 reported that fatigue has consequences 
for activities such as socialising, spending time with loved 
ones and participating in other life activities. Such added 
burden appears to amplify the relentless nature of HD 
and contributes to a sense that patients are enduring 
their circumstances and are stuck, having no choice but 
to continue in order to survive.
Despite being forthcoming about the negative aspects 
of HD, the patients in this study recognised the impor-
tance of maintaining a positive outlook about their 
circumstances, acknowledging that HD has provided 
them with a lifeline. The sense of a renewed or extended 
life facilitated by cognitive reappraisal of patient circum-
stances concurs with the views expressed by HD patients 
in other studies.12 28 29 Additionally, part of maintaining a 
positive outlook involved living in the moment and taking 
each day as it comes. Such an approach has also been 
unearthed in carers of patients with ESKD as a mechanism 
to cope with uncertainty.31 The development of a positive 
outlook may be an adaptive process to the demands of 
HD and an important constructive coping strategy.
Support from the family was also an important coping 
resource. Family offered both practical support and 
emotional comfort. There is a wealth of research delin-
eating the positive impact of perceived social support in 
the context of HD. For example, a study of Iranian HD 
patients found that perceived social support was asso-
ciated with quality of life.32 Social support also has a 
positive impact on patient adherence and mood on dial-
ysis.33 34 Hence for patients from BAME backgrounds, it 
is important to focus on understanding support networks 
to facilitate achievement of acceptable quality of life and 
health outcomes. This is particularly relevant where there 
are language barriers and family support is required facil-
itate engagement with treatment.
Although we did not specifically enquire about the 
patient–clinician relationship, this emerged as an 
important theme in our data. Many patients reported 
issues in the amount of time they perceived receiving 
from nephrologists and mixed experiences of the quality 
of patient–clinician interactions. It is not uncommon for 
members of ethnic minorities to report negative experi-
ences of interactions with physicians.35 36 However, diffi-
culties in relationships with healthcare professionals are 
not limited to those from ethnic minorities. Longitudinal 
participatory action research conducted with English 
speaking HD patients in Canada found that perceived 
failure of healthcare professionals to interact with the 
patient as a whole person led to a lack of trust.37 What 
may be unique to patients from ethnic minorities are the 
added language barriers that may further limit the quality 
of interactions. Strategies to improve rapport need to 
include the broader family network since this is a major 
source of patient support.
A notable finding relates to kidney transplantation 
being perceived as a route to optimising quality of life. 
Indeed, kidney transplantation is the most desirable and 
economic form of renal replacement therapy (RRT), 
offering the best outcomes.38 However, it is true that due 
to low rates of organ donation among those from BAME 
backgrounds, these patients can expect to wait on average 
up to a year longer for a kidney transplant compared with 
their white counterparts.20 Our patients believed that 
there is a lack of knowledge and awareness surrounding 
organ donation in their communities as compared with 
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those from white-European backgrounds and particularly 
regarding live donation as they encountered difficulty  in 
discussing donation with friends and family. Such feelings 
may be a further challenge to adaptation to HD.39
There are multiple reasons for lower rates of organ dona-
tion among BAME groups. Morgan et al20 summarised 
them into five main themes: a lack of knowledge about 
organ donation and how to register to become a donor, 
faith and cultural beliefs, bodily concerns, family influ-
ence and trust in the healthcare system. Morgan et al20 
suggest that tailored community-based educational 
interventions may be more beneficial for improving 
rates of donation among BAME groups over mass media 
campaigns. Although rates of live donation are equivalent 
to those of other ethnic groups,40 more efforts appear to 
be required to both raise awareness of the success of live 
donation and to encourage deceased donation. It may 
also be important to empower patients so that they feel 
able to initiate discussions around live donation, although 
research suggests that it may be useful to separate the 
patient from the advocate.41 Initiatives such as communi-
ty-based peer educators in BAME communities may help 
address the spectrum of issues related to kidney disease.42
strengths and limitations
Patients from BAME backgrounds are under-repre-
sented in renal research due to language and cultural 
barriers.14 By providing an opportunity to contribute to 
focus groups in their language of origin that were facili-
tated by project workers unrelated to renal care, the study 
has helped capture the treatment experiences of a major 
group of HD patients in the UK. Recruitment across four 
NHS Renal Units also helped ensure diverse perspectives 
from those receiving care at different centres. There are 
some limitations: (1) the self-selecting nature of the study 
participants may have introduced bias into the study and 
it is plausible that only patients with strong views about 
HD participated. This may explain why our findings share 
a high level of similarity with other qualitative studies in 
the area of HD. (2) The number of participants included 
in each focus group was relatively small and the reasons 
for non-participation largely unknown.
COnClusIOns
This study contributes new knowledge about how HD is 
experienced by patients from South Asian backgrounds 
in a UK renal care setting. The findings support the need 
to help all patients in adapting to the HD treatment 
regimen including the usefulness of developing positive 
coping strategies. For patients where language barriers 
impede the formation of the patient–clinician relation-
ships, it is essential to involve the wider support network 
effectively in healthcare discussions and in a way that 
empowers patients in managing their illness. Campaigns 
aimed at addressing the shortage of donor organs should 
be encouraged to improve hopefulness for normality and 
ultimately rates of access to kidney transplantation for 
those from BAME backgrounds.
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